Recruitment into the Alzheimer Prevention Trials (APT) Webstudy for a Trial-Ready Cohort for Preclinical and Prodromal Alzheimer’s Disease (TRC-PAD) - 21/11/24

Doi : 10.14283/jpad.2020.46 
S. Walter 1, , , T.B. Clanton 1, O.G. Langford 1, M.S. Rafii 1, E.J. Shaffer 1, J.D. Grill 3, G.A. Jimenez-Maggiora 1, R.A. Sperling 2, J.L. Cummings 4, 5, P.S. Aisen 1

TRC-PAD Investigators

1 Alzheimer’s Therapeutic Research Institute, University of Southern California, San Diego, CA, USA 
2 Center for Alzheimer Research and Treatment, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA 
3 Institute for Memory Impairments and Neurological Disorders, University of California, Irvine, USA 
4 Department of Brain Health, School of Integrated Health Sciences, University of Las Vegas, Las Vegas, Nevada, USA 
5 Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, USA 

a waltersa@usc.edu

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Abstract

Background

The Alzheimer Prevention Trials (APT) Webstudy is the first stage in establishing a Trial-ready Cohort for Preclinical and Prodromal Alzheimer’s disease (TRC-PAD). This paper describes recruitment approaches for the APT Webstudy.

Objectives

To remotely enroll a cohort of individuals into a web-based longitudinal observational study. Participants are followed quarterly with brief cognitive and functional assessments, and referred to Sites for in-clinic testing and biomarker confirmation prior to enrolling in the Trial-ready Cohort (TRC).

Design

Participants are referred to the APT Webstudy from existing registries of individuals interested in brain health and Alzheimer’s disease research, as well as through central and site recruitment efforts. The study team utilizes Urchin Tracking Modules (UTM) codes to better understand the impact of electronic recruitment methods.

Setting

A remotely enrolled online study.

Participants

Volunteers who are at least 50 years old and interested in Alzheimer’s research.

Measurements

Demographics and recruitment source of participant where measured by UTM.

Results

30,650 participants consented to the APT Webstudy as of April 2020, with 69.7% resulting from referrals from online registries. Emails sent by the registry to participants were the most effective means of recruitment. Participants are distributed across the US, and the demographics of the APT Webstudy reflect the referral registries, with 73.1% female, 85.0% highly educated, and 92.5% Caucasian.

Conclusions

We have demonstrated the feasibility of enrolling a remote web-based study utilizing existing registries as a primary referral source. The next priority of the study team is to engage in recruitment initiatives that will improve the diversity of the cohort, towards the goal of clinical trials that better represent the US population.

Il testo completo di questo articolo è disponibile in PDF.

Key words : Trial-ready cohort, online registry, remote recruitment, web-based, preclinical, Alzheimer’s disease, prevention


Mappa


 TRC-PAD Investigators are listed at www.trcpad.org
 Conflict of interest: The authors report grants from National Institute on Aging, during the conduct of the study. None of the authors have additional financial interests, relationships or affiliations relevant to the subject of this manuscript.


© 2020  THE AUTHORS. Published by Elsevier Masson SAS on behalf of SERDI Publisher.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 7 - N° 4

P. 219-225 - Settembre 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Predicting Amyloid Burden to Accelerate Recruitment of Secondary Prevention Clinical Trials
  • O. Langford, R. Raman, R.A. Sperling, J. Cummings, C.-K. Sun, G. Jimenez-Maggiora, P.S. Aisen, M.C. Donohue, TRC-PAD Investigators
| Articolo seguente Articolo seguente
  • TRC-PAD: Accelerating Recruitment of AD Clinical Trials through Innovative Information Technology
  • G.A. Jimenez-Maggiora, S. Bruschi, R. Raman, O. Langford, M. Donohue, M.S. Rafii, R.A. Sperling, J.L. Cummings, P.S. Aisen, TRC-PAD Investigators

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.